Background: Sweating can worsen atopic dermatitis (AD). The purpose of this work was to study the associations between reactivity to autologous sweat and the clinical severity of AD as well as investigate the possible wheal-inducing factors of sweat. Methods: Intracutaneous skin tests with autologous sweat were performed on 50 AD patients and 24 control subjects. In skin biopsies, tryptase and PAR-2 were enzyme and immunohistochemically stained. The associations between skin test reactivity and sweat histamine concentration, tryptase or chymase activity levels, tryptase or PAR-2 expression and AD clinical severity or IgE levels were investigated. Results: The wheal reactions in the intracutaneous tests with autologous sweat were positive, weakly positive and negative in 38, 34 and 28% of the AD patients, respectively, and in 4, 46 and 50% of the healthy controls, respectively (p = 0.008). In AD, the wheal reaction was associated significantly with clinical severity, serum total and specific IgE levels and sweat tryptase activity, but not with sweat histamine and chymase. In nonlesional AD skin, the percentage of PAR-2+ mast cells (MCs) or the number of tryptase+ MCs did not differ significantly between the intracutaneous test reactivity groups. Conclusion: Reactivity to autologous sweat correlates with the clinical severity of AD, and tryptase may be one of the factors involved in the sweat-induced wheal.

Keywords:
Autologous sweat, Atopic dermatitis, Tryptase, IgE, Malassezia
1.
Hiragun T, Ishii K, Hiragun M, Suzuki H, Kan T, Mihara S, Yanase Y, Bartels J, Schröder JM, Hide M: Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients. J Allergy Clin Immunol 2013;132:608-615.e4.
2.
Dai X, Okazaki H, Hanakawa Y, Murakami M, Tohyama M, Shirakata Y, Sayama K: Eccrine sweat contains IL-1alpha, IL-1beta and IL-31 and activates epidermal keratinocytes as a danger signal. PLoS One 2013;8:e67666.
3.
Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S: IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 2002;82:335-340.
4.
Adachi K, Aoki T: IgE antibody to sweat in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:83-87.
5.
Jung K, Schlenvoigt G, Ladwig K, Herrmann D, Moths C, Linse R, Neumann C: The sweat of patients with atopic dermatitis contains specific IgE antibodies to inhalant allergens. Clin Exp Dermatol 1996;21:347-350.
6.
Kempkes C, Buddenkotte J, Cevikbas F, Buhl T, Steinhoff M: Role of PAR-2 in neuroimmune communication and itch; in Carstens E, Akiyama T (eds): Itch: Mechanisms and Treatment. Boca Raton, CRC Press/Taylor & Francis, 2014, pp 193-212.
7.
Tsujii K, Andoh T, Ui H, Lee JB, Kuraishi Y: Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis. J Pharmacol Sci 2009;109:388-395.
8.
Jarvikallio A, Harvima IT, Naukkarinen A: Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003;295:2-7.
9.
Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M: Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23:6176-6180.
10.
Moormann C, Artuc M, Pohl E, Varga G, Buddenkotte J, Vergnolle N, Brehler R, Henz BM, Schneider SW, Luger TA, Steinhoff M: Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 2006;126:746-755.
11.
Ohsawa Y, Hirasawa N: The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study. Allergol Int 2014;63:533-542.
12.
Teresiak-Mikolajczak E, Czarnecka-Operacz M, Jenerowicz D, Silny W: Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus. Postepy Dermatol Alergol 2013;30:286-292.
13.
Harvima IT, Nilsson G, Suttle MM, Naukkarinen A: Is there a role for mast cells in psoriasis? Arch Dermatol Res 2008;300:461-478.
14.
Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:13-14.
15.
Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto ML, Schwartz LB, Horsmanheimo M: Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993;285:184-192.
16.
Harvima RJ, Harvima IT, Fräki JE: Optimization of histamine radio enzyme assay with purified histamine-N-methyltransferase. Clin Chim Acta 1988;171:247-256.
17.
Huttunen M, Harvima IT: Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol 2005;152:1149-1160.
18.
Carvalho RF, Nilsson G, Harvima IT: Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation. Exp Dermatol 2010;19:117-122.
19.
Adachi J, Endo K, Fukuzumi T, Kojima M, Aoki T: Negative patch test reactions to sweat in atopic dermatitis. Acta Derm Venereol 1996;76:410-411.
20.
Johansson C, Sandström MH, Bartosik J, Särnhult T, Christiansen J, Zargari A, Bäck O, Wahlgren CF, Faergemann J, Scheynius A, Tengvall Linder M: Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol 2003;148:479-488.
21.
Glatz M, Buchner M, von Bartenwerffer W, Schmid-Grendelmeier P, Worm M, Hedderich J, Fölster-Holst R: Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol 2015;95:191-196.
22.
Hiragun M, Hiragun T, Ishii K, Suzuki H, Tanaka A, Yanase Y, Mihara S, Haruta Y, Kohno N: Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria. Allergol Int 2014;63:83-93.
23.
Zhang E, Tanaka T, Tajima M, Tsuboi R, Kato H, Nishikawa A, Sugita T: Anti-Malassezia-specific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: relationship between the level of specific IgE antibody and the colonization frequency of cutaneous Malassezia species and clinical severity. J Allergy (Cairo) 2011;2011:645670.
24.
Brodska P, Panzner P, Pizinger K, Schmid-Grendelmeier P: IgE-mediated sensitization to Malassezia in atopic dermatitis: more common in male patients and in head and neck type. Dermatitis 2014;25:120-126.
25.
Mayser P, Gross A: IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm Venereol 2000;80:357-361.
26.
Zargari A, Midgley G, Bäck O, Johansson SG, Scheynius A: IgE-reactivity to seven Malassezia species. Allergy 2003;58:306-311.
27.
Sugita T, Suto H, Unno T, Tsuboi R, Ogawa H, Shinoda T, Nishikawa A: Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol 2001;39:3486-3490.
28.
Gupta AK, Kohli Y, Summerbell RC, Faergemann J: Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001;39:243-251.
29.
Andersson A, Rasool O, Schmidt M, Kodzius R, Flückiger S, Zargari A, Crameri R, Scheynius A: Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase. Eur J Biochem 2004;271:1885-1894.
30.
Schmid-Grendelmeier P, Flückiger S, Disch R, Trautmann A, Wüthrich B, Blaser K, Scheynius A, Crameri R: IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005;115:1068-1075.
31.
Järvikallio A, Naukkarinen A, Harvima IT, Aalto ML, Horsmanheimo M: Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997;136:871-877.
32.
Kyoya M, Kawakami T, Soma Y: Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis. J Dermatol Sci 2014;75:204-207.
33.
Dvorak AM: Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease. Immunol Ser 1992;57:169-271.
34.
Selander C, Engblom C, Nilsson G, Scheynius A, Andersson CL: TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol 2009;182:4208-4216.
35.
Kaminska R, Naukkarinen A, Horsmanheimo M, Harvima IT: Suction blister formation in skin after acute and repeated mast cell degranulation. Acta Derm Venereol 1999;79:191-194.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.